Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000711416 | SCV000841781 | uncertain significance | not provided | 2017-09-11 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001836871 | SCV002098010 | uncertain significance | Intellectual disability-epilepsy-extrapyramidal syndrome | 2020-06-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000711416 | SCV002384429 | likely benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532912 | SCV003731873 | benign | Inborn genetic diseases | 2022-02-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004535762 | SCV004752492 | likely benign | DEAF1-related disorder | 2020-08-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |